Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salnikow, K.
Right arrow Articles by Blagosklonny, M. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salnikow, K.
Right arrow Articles by Blagosklonny, M. V.
[Cancer Research 60, 5630-5634, October 15, 2000]
© 2000 American Association for Cancer Research

Advances in Brief

Hyperinducibility of Hypoxia-responsive Genes without p53/p21-dependent Checkpoint in Aggressive Prostate Cancer1

Konstantin Salnikow2, Max Costa, William D. Figg1 and Mikhail V. Blagosklonny2

Nelson Institute of Environmental Medicine, and Kaplan Comprehensive Cancer Center, New, York University School of Medicine, New York, New York 10016 [K. S., M. C.], and Medicine Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892 [W. D. F. and M. V. B.]

Hypoxia limits tumor growth but selects for higher metastatic potential. We tested the functional activity of hypoxia-inducible factor-1 (HIF-1) in prostate cell lines ranging from normal epithelial cells (PrEC), hormone-dependent LNCaP, hormone-independent DU145, PC-3 to highly metastatic PC-3M cancer cell lines. We found that HIF-1-stimulated transcription was the lowest in PrEC and LNCaP cells and the highest in PC-3M cells. The induction by hypoxia of the HIF-1 dependent genes Cap43 and GAPDH was the highest in the most aggressive PC-3M cancer cells. Because these advanced prostate cancer cell lines have lost p53 function, this further shifts a balance from p53 to HIF-1 transcriptional regulation, and a high ratio of HIF-1-dependent:p53-dependent transcription was a marker of the advanced malignant phenotype. Transient transfection of HIF-1{alpha} expression vector induced transcription from p21 promoter construct in prostate cancer cell lines. Furthermore, hypoxia slightly induced p21 mRNA in these cells. However, neither expression of p21 nor hypoxia caused growth arrest in PC-3M cells. Therefore, high inducibility of HIF-1-dependent genes, loss of p53 functions with high ratio of HIF-1-dependent:p53-dependent transcription, and loss of sensitivity to p21 inhibition is a part of hypoxic phenotype associated with aggressive cancer behavior.




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
T. P. Ellen, Q. Ke, P. Zhang, and M. Costa
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states
Carcinogenesis, January 1, 2008; 29(1): 2 - 8.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Chen, D. M. Nelson, and Y. Sadovsky
N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury
J. Biol. Chem., February 3, 2006; 281(5): 2764 - 2772.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
U. Wimmer, Y. Wang, O. Georgiev, and W. Schaffner
Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione
Nucleic Acids Res., October 12, 2005; 33(18): 5715 - 5727.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
Z. Dong, R. J. Arnold, Y. Yang, M. H. Park, P. Hrncirova, Y. Mechref, M. V. Novotny, and J.-T. Zhang
Modulation of Differentiation-related Gene 1 Expression by Cell Cycle Blocker Mimosine, Revealed by Proteomic Analysis
Mol. Cell. Proteomics, July 1, 2005; 4(7): 993 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
D M Peehl
Primary cell cultures as models of prostate cancer development
Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Kaluzova, S. Kaluz, M. I. Lerman, and E. J. Stanbridge
DNA Damage Is a Prerequisite for p53-Mediated Proteasomal Degradation of HIF-1{alpha} in Hypoxic Cells and Downregulation of the Hypoxia Marker Carbonic Anhydrase IX
Mol. Cell. Biol., July 1, 2004; 24(13): 5757 - 5766.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Li, G. Davidson, Y. Huang, B.-H. Jiang, X. Shi, M. Costa, and C. Huang
Nickel Compounds Act through Phosphatidylinositol-3-kinase/Akt-Dependent, p70S6k-Independent Pathway to Induce Hypoxia Inducible Factor Transactivation and Cap43 Expression in Mouse Epidermal Cl41 Cells
Cancer Res., January 1, 2004; 64(1): 94 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. P. Caruso, B. Levinson, J. Melamed, R. Wieczorek, S. Taneja, D. Polsky, C. Chang, A. Zeleniuch-Jacquotte, K. Salnikow, H. Yee, et al.
Altered N-myc Downstream-Regulated Gene 1 Protein Expression in African-American Compared with Caucasian Prostate Cancer Patients
Clin. Cancer Res., January 1, 2004; 10(1): 222 - 227.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
B. Malette, E. Cherry, M. Lagace, M. Bernard, D. Gosselin, P. Hugo, and K. Shazand
Large scale validation of human N-myc Downstream-Regulated Gene (NDRG)-1 expression in endometrium during the menstrual cycle
Mol. Hum. Reprod., November 1, 2003; 9(11): 671 - 679.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. J. Mabjeesh, M. T. Willard, C. E. Frederickson, H. Zhong, and J. W. Simons
Androgens Stimulate Hypoxia-inducible Factor 1 Activation via Autocrine Loop of Tyrosine Kinase Receptor/Phosphatidylinositol 3'-Kinase/Protein Kinase B in Prostate Cancer Cells
Clin. Cancer Res., July 1, 2003; 9(7): 2416 - 2425.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
P. Loukopoulos, J. R. Thornton, and W. F. Robinson
Clinical and Pathologic Relevance of p53 Index in Canine Osseous Tumors
Vet. Pathol., May 1, 2003; 40(3): 237 - 248.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
N. Goda, H. E. Ryan, B. Khadivi, W. McNulty, R. C. Rickert, and R. S. Johnson
Hypoxia-Inducible Factor 1{alpha} Is Essential for Cell Cycle Arrest during Hypoxia
Mol. Cell. Biol., January 1, 2003; 23(1): 359 - 369.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
E. Laughner, P. Taghavi, K. Chiles, P. C. Mahon, and G. L. Semenza
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1{alpha} (HIF-1{alpha}) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
Mol. Cell. Biol., June 15, 2001; 21(12): 3995 - 4004.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
M. V. Blagosklonny, P. Giannakakou, L. Y. Romanova, K. M. Ryan, K. H. Vousden, and T. Fojo
Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions
Carcinogenesis, June 1, 2001; 22(6): 861 - 867.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. V. Blagosklonny and A. B. Pardee
Exploiting Cancer Cell Cycling for Selective Protection of Normal Cells
Cancer Res., June 1, 2001; 61(11): 4301 - 4305.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Das, R. Hammamieh, R. Neill, M. Melhem, and M. Jett
Expression Pattern of Fatty Acid-binding Proteins in Human Normal and Cancer Prostate Cells and Tissues
Clin. Cancer Res., June 1, 2001; 7(6): 1706 - 1715.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.